Hedge Fund - Weiss Asset Management
Theravance Biopharma Inc. (TBPH)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $139,521,593 | 1.95% | 7,457,060 | $16.59 |
| 2 | 2025 - Q3 (2025-09-30) | $108,873,076 | 1.27% | 7,457,060 | $12.64 |
| 3 | 2025 - Q2 (2025-06-30) | $82,251,372 | 0.93% | 7,457,060 | $9.72 |
| 4 | 2025 - Q1 (2025-03-31) | $66,591,546 | 1.33% | 7,457,060 | $9.31 |
| 5 | 2024 - Q4 (2024-12-31) | $70,170,935 | 1.31% | 7,457,060 | $9.10 |
| 6 | 2024 - Q3 (2024-09-30) | $60,103,904 | 1.31% | 7,457,060 | $8.66 |
| 7 | 2024 - Q2 (2024-06-30) | $63,235,869 | 2.38% | 7,457,060 | $9.03 |
| 8 | 2024 - Q1 (2024-03-31) | $66,889,828 | 2.29% | 7,457,060 | $9.27 |
| 9 | 2023 - Q4 (2023-12-31) | $83,817,354 | 4% | 7,457,060 | $10.06 |
| 10 | 2023 - Q3 (2023-09-30) | $64,354,428 | 3.81% | 7,457,060 | $9.65 |
| 11 | 2023 - Q2 (2023-06-30) | $77,180,571 | 5.91% | 7,457,060 | $11.04 |
| 12 | 2023 - Q1 (2023-03-31) | $80,909,101 | 5.17% | 7,457,060 | $10.57 |
| 13 | 2022 - Q4 (2022-12-31) | $83,668,213 | 3.4% | 7,457,060 | $10.51 |
| 14 | 2022 - Q3 (2022-09-30) | $75,615,000 | 0.67% | 7,457,060 | $9.37 |
| 15 | 2022 - Q2 (2022-06-30) | $56,511,000 | 0.5% | 6,237,438 | $9.21 |
| 16 | 2022 - Q1 (2022-03-31) | $51,743,000 | 0.43% | 5,412,487 | $9.80 |
| 17 | 2021 - Q4 (2021-12-31) | $28,750,000 | 0.46% | 2,601,778 | $8.72 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center